# A Real-World Registry Investigating TReprostInil sodiUM in Pulmonary Hypertension (Re-TRIUMPH)

> **NCT05553015** · — · UNKNOWN · sponsor: **Chinese Pulmonary Vascular Disease Research Group** · enrollment: 450 (estimated)

## Conditions studied

- Pulmonary Hypertension
- Medication Therapy Management

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05553015
- **Lead sponsor:** Chinese Pulmonary Vascular Disease Research Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-24
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05553015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05553015, "A Real-World Registry Investigating TReprostInil sodiUM in Pulmonary Hypertension (Re-TRIUMPH)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05553015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*